The Effect of Metformin on Pituitary Function in Postmenopausal Women with Subclinical Hypothyroidism and Macroprolactinemia: A Single-Center Prospective Case–Control Study [PDF]
Background/Objectives: Metformin inhibits secretory function of overactive thyrotrophs, gonadotrophs, and lactotrophs. The clinical significance of an excess of high-molecular-weight prolactin (macroprolactinemia) remains unclear.
Robert Krysiak +3 more
doaj +3 more sources
The Validation of Macroprolactin Analysis by Polyethylene Glycol Precipitation Using Fujirebio Lumipulse [PDF]
Sjoerd A A van den Berg, Febe C Vermue
exaly +4 more sources
Comparison of urinary prolactin and serum/urine prolactin ratio in hyperprolactinemic and macroprolactinemic patients [PDF]
Background Biologically, the monomeric form of prolactin is the most active. In measurement methods, all forms of prolactin are included in the assay; therefore, the presence of macroprolactin, causes a false increase in prolactin and misdiagnosis of ...
Behnam Ein-Mozaffari +8 more
doaj +2 more sources
Macrohormones in endocrinology: prevalence, clinical impact, and diagnostic approaches [PDF]
Macrohormones also called macromolecules or macrocomplexes are described as an antigen-antibody complex, consisting of monomeric hormones bound to immunoglobulins. These molecules exhibit minimal or no biological activity.
Agata Bronisławska +10 more
doaj +2 more sources
Prevalence of Macroprolactinaemia in Women with Hyperprolactinaemia: A Retrospective Study [PDF]
Introduction: Macroprolactinaemia causes asymptomatic hyperprolactinaemia in many patients which leads to misdiagnosis, inappropriate investigation and needless treatment in these patients.
Flavia Almeida +4 more
doaj +2 more sources
Polyendocrine–Metabolic Profile in Adolescents and Young Women with Ovulatory Dysfunction: A Cross-Sectional Study [PDF]
(1) Background: Ovulatory dysfunction (OD) is frequently the first clinical expression of an underlying polyendocrine or metabolic disturbance. In the context of the international consensus renaming polycystic ovary syndrome (PCOS) as polyendocrine ...
Juan Pablo Del Río +6 more
doaj +2 more sources
The Correlation Between DRD2 and COMT Gene Polymorphisms, HPT and HPG Axes Functions, and Antipsychotic Drug-Induced Hyperprolactinemia and Macroprolactinemia [PDF]
Zhenhua Wang,1 Jing Li,2 Haizhi Chen,1 Haiying Jin,1 Shiliang Wang,1 Xuqiang Hu1 1Department of Psychiatry, Huzhou Third Municipal Hospital, the Affiliated Hospital of Huzhou University, Huzhou, Zhejiang, People’s Republic of China; 2Center for Disease ...
Wang Z +5 more
doaj +2 more sources
Diagnosis of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM) [PDF]
Hyperprolactinemia is a frequent cause of menstrual irregularity, galactorrhea, hypogonadism, and infertility. The most common etiologies of hyperprolactinemia can be classified as physiological, pharmacological, and pathological.
Andrea Glezer +9 more
doaj +2 more sources
Mild hyperprolactinemia in women with polycystic ovary syndrome. Insights from a large cross-sectional study [PDF]
Background: Hyperprolactinemia is an exclusion criterion for polycystic ovary syndrome (PCOS), albeit PCOS itself is argued to induce mild hyperprolactinemia.
Manuel Luque-Ramírez +6 more
doaj +2 more sources
Prevalence of Macroprolactinaemia by Polyethylene Glycol Precipitation Method: A Cross-sectional Study [PDF]
Introduction: Macroprolactin, an immunoreactive molecule resulting from association of monomeric Prolactin (mPRL) and immunoglobulin G is a significant cause of misdiagnosis, unnecessary radiological investigation and treatment for ...
RAGHUNATH BHATTACHARYYA +4 more
doaj +1 more source

